Immunocore Holdings plc (IMCR) Misses Q4 EPS by 20c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q4 EPS of ($0.40), $0.20 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $70.16 million versus the consensus estimate of $53.23 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• Intuitive Machines, Inc. (LUNR) Misses Q2 EPS by 20c, Misses on Revenue; Offers FY26 Revenue Guidance
• NextPlat Corp (NXPL) Reports Q2 Loss of $0.05